drugset / Trial / NCT06374017

Evaluation of Lidocaine Spray Versus Dexmetomidine Spray on Stress Response

NCT06374017 ↗

Phase 4 Completed 120 enrolled Kasr El Aini Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Many studies discussed attenuating stress response by various measures but to the interest of our study , No one compared topical spray of both lidocaine and dexmedetomidine in attenuating the haemodynamic stress responses of laryngoscopy and endotracheal intubation, avoiding undesired systemic effects of drugs ,

Timeline

Start
2024-04-20
Primary completion
2024-12-30
Completion
2025-01-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Other
Comparator Lidocaine Other / unclassified 100 mg Other

Indications

No indication recorded.